Schizophrenia Trial, Recruiting (NCT07139171)

Schizophrenia Trial, Recruiting NCT07139171 Sponsor: Tianjin Anding Hospital Condition: Schizophrenia

Printed from Voxsanity (voxsanity.com.au) — NCT07139171 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Schizophrenia

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You are a healthy volunteer who matches other participants in the study in terms of sex, age, and education level
None of your close relatives (parents, siblings, children, grandparents, aunts, or uncles) have been diagnosed with a mental health condition
You are of Han Chinese ethnicity
You are willing and able to sign a written consent form agreeing to take part

Who may not be able to join:

You have a serious physical health condition, such as uncontrolled high blood pressure, serious heart, brain, lung, thyroid, or metabolic disease, diabetes, epilepsy, or metabolic syndrome
You have ever been diagnosed with, or currently have, a mental health condition related to substance use, delusions, a brief psychotic episode, or a mood disorder involving psychotic symptoms
You are currently pregnant or breastfeeding
You have any condition that would make it difficult for you to understand and agree to take part, or to complete the study activities (confirm with trial site)

⚠️ Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 28 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +86-022-88188006

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT07139171

Sponsor: Tianjin Anding Hospital

Phase: Not Applicable

Status: Recruiting

Condition: Schizophrenia

Trial contact: +86-022-88188006

More information: https://clinicaltrials.gov/study/NCT07139171

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You are a healthy volunteer who matches other participants in the study in terms of sex, age, and education level
None of your close relatives (parents, siblings, children, grandparents, aunts, or uncles) have been diagnosed with a mental health condition
You are of Han Chinese ethnicity
You are willing and able to sign a written consent form agreeing to take part

Who may not be able to join:

You have a serious physical health condition, such as uncontrolled high blood pressure, serious heart, brain, lung, thyroid, or metabolic disease, diabetes, epilepsy, or metabolic syndrome
You have ever been diagnosed with, or currently have, a mental health condition related to substance use, delusions, a brief psychotic episode, or a mood disorder involving psychotic symptoms
You are currently pregnant or breastfeeding
You have any condition that would make it difficult for you to understand and agree to take part, or to complete the study activities (confirm with trial site)

⚠️ Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 28 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Tianjin Anding Hospital

Registry

ClinicalTrials.gov

Start date

11 November 2022

Est. completion

1 October 2025

Where this trial is recruiting

🇨🇳 China

Primary endpoints

Cognitive Function; Plasma Exosome Concentration; The MicroRNA Expression Profile; Plasma Exosome Size Distribution

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov